Large dissemination of VIM-2-metallo-β-lactamase-producing Pseudomonas aeruginosa strains causing health care-associated community-onset infections

Journal of Clinical Microbiology

Volumn 47, Issue 11, 2009, Pages 3524-3529

  Tsakris, Athanassios ^a   Poulou, Aggeliki ^b   Kristo, Ioulia ^c   Pittaras, Theodore ^a   Spanakis, Nicholas ^a   Pournaras, Spyros ^c   Markou, Fani ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b General District Hospital of Serres   (Greece)

^c UNIVERSITY OF THESSALY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BLA VIM 2 METALLO BETA LACTAMASE; CARBAPENEM; METALLO BETA LACTAMASE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CLINICAL ARTICLE; COMMUNITY ONSET URINARY TRACT INFECTION; CONTROLLED STUDY; FEMALE; HEALTH CARE FACILITY; HEALTH SURVEY; HOSPITAL INFECTION; HUMAN; MALE; NONHUMAN; OUTPATIENT; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; PULSED FIELD GEL ELECTROPHORESIS; RECURRENT INFECTION; URINARY TRACT INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CLUSTER ANALYSIS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DNA FINGERPRINTING; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; INTEGRONS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; URINARY TRACT INFECTIONS;

PSEUDOMONAS AERUGINOSA;

EID: 70449674721     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01099-09     Document Type: Article

References (29)

1. Arpin, C., V. Dubois, J. Maugein, J. Jullin, B. Dutilh, J. P. Brochet, G. Larribet, I. Fischer, and C. Quentin. 2005. Clinical and molecular analysis of extended-spectrum β-lactamase-producing enterobacteria in the community setting. J. Clin. Microbiol. 43:5048-5054.
2. Calbo, E., V. Romani, M. Xercavins, L. Gómez, C. G. Vidal, S. Quintana, J. Vila, and J. Garau. 2006. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum β-lactamases. J. Antimicrob. Chemother. 57:780-783.
3. SPM clone, spread in hospitals in a Brazilian Amazon city. Microb. Drug Resist. 13:142-146.
4. Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial susceptibility testing; 18th informational supplement. CLSI M100-S18. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Cornaglia, G., A. Mazzariol, L. Lauretti, G. M. Rossolini, and R. Fontana. 2000. Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-β-lactamase. Clin. Infect. Dis. 31:1119-1125.
6. IMP-7. Antimicrob. Agents Chemother. 46:255-258.
7. Horan, T. C., M. Andrus, and M. A. Dudeck. 2008. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am. J. Infect. Control 36:309-332.
8. Horianopoulou, M., N. J. Legakis, M. Kanellopoulou, S. Lambropoulos, A. Tsakris, and M. E. Falagas. 2006. Frequency and predictors of colonization of the respiratory tract by VIM-2-producing Pseudomonas aeruginosa in patients of a newly established intensive care unit. J. Med. Microbiol. 55:1435-1439.
9. Huang, Y. T., S. C. Chang, T. L. Lauderdale, A. J. Yang, and J. T. Wang. 2007. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa carrying metallo-β-lactamase genes in Taiwan. Diagn. Microbiol. Infect. Dis. 59:211-216.
10. Kaufmann, M. E., and T. L. Pitt. 1994. Pulsed-field gel electrophoresis of bacterial DNA, p. 83-92. In Henrik Chart (ed.), Methods in practical laboratory bacteriology. CRC Press, London, United Kingdom.
11. Lagatolla, C., E. Edalucci, L. Dolzani, M. L. Riccio, F. De Luca, E. Medessi, G. M. Rossolini, and E. A. Tonin. 2006. Molecular evolution of metallo-β-lactamase-producing Pseudomonas aeruginosa in a nosocomial setting of high-level endemicity. J. Clin. Microbiol. 44:2348-2353.
12. Lee, N. Y., J. J. Yan, H. C. Lee, K. H. Liu, S. T. Huang, and W. C. Ko. 2004. Clinical experiences of bacteremia caused by metallo-β-lactamase- producing gram-negative organisms. J. Microbiol. Immunol. Infect. 37:343-349.
13. Lévesque, C., L. Piche, C. Larose, and P. H. Roy. 1995. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob. Agents Chemother. 39:185-191.
14. Marra, A. R., C. A. Pereira, A. C. Gales, L. C. Menezes, R. G. Cal, J. M. de Souza, M. B. Edmond, C. Faro, and S. B. Wey. 2006. Bloodstream infections with metallo-β-lactamase-producing Pseudomonas aeruginosa: epidemiology, microbiology, and clinical outcomes. Antimicrob. Agents Chemother. 50:388-390.
15. Peña, C., C. Suarez, F. Tubau, O. Gutierrez, A. Domínguez, A. Oliver, M. Pujol, F. Gudiol, and J. Ariza. 2007. Nosocomial spread of Pseudomonas aeruginosa producing the metallo-β-lactamase VIM-2 in a Spanish hospital: clinical and epidemiological implications. Clin. Microbiol. Infect. 13:1026-1029.
16. VIM-2 carbapenem-hydrolyzing β-lactamase gene and of two novel aminoglycoside resistance gene cassettes. Antimicrob. Agents Chemother. 45:546-552.
17. VIM-4. J. Antimicrob. Chemother. 51:1409-1414.
18. Queenan, A. M., and K. Bush. 2007. Carbapenemases: the versatile β-lactamases. Clin. Microbiol. Rev. 20:440-458.
19. Quinteira, S., and L. Peixe. 2006. Multiniche screening reveals the clinically relevant metallo-β-lactamase VIM-2 in Pseudomonas aeruginosa far from the hospital setting: an ongoing dispersion process? Appl. Environ. Microbiol. 72:3743-3745.
20. VIM-17 metallo-β-lactamase gene. Antimicrob. Agents Chemother. 53:1325-1330.
21. Tam, V. H., K. T. Chang, M. T. LaRocco, A. N. Schilling, S. K. McCauley, K. Poole, and K. W. Garey. 2007. Prevalence, mechanisms, and risk factors of carbapenem resistance in bloodstream isolates of Pseudomonas aeruginosa. Diagn. Microbiol. Infect. Dis. 58:309-314.
22. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
23. Tsakris, A., A. Ikonomidis, A. Poulou, N. Spanakis, S. Pournaras, and F. Markou. 2007. Transmission in the community of clonal Proteus mirabilis carrying VIM-1 metallo-β-lactamase. J. Antimicrob. Chemother. 60:136-139.
24. Tsakris, A., S. Pournaras, N. Woodford, M. F. Palepou, G. S. Babini, J. Douboyas, and D. M. Livermore. 2000. Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J. Clin. Microbiol. 38:1290-1292.
25. Tzelepi, E., C. Magana, E. Platsouka, D. Sofianou, O. Paniara, N. J. Legakis, A. C. Vatopoulos, and L. S. Tzouvelekis. 2003. Extended-spectrum β-lactamase types in Klebsiella pneumoniae and Escherichia coli in two Greek hospitals. Int. J. Antimicrob. Agents 21:285-288.
26. Walsh, T. R. 2008. Clinically significant carbapenemases: an update. Curr. Opin. Infect. Dis. 21:367-371.
27. Yan, J. J., P. R. Hsueh, W. C. Ko, K. T. Luh, S. H. Tsai, H. M. Wu, and J. J. Wu. 2001. Metallo-β-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob. Agents Chemother. 45:2224-2228.
28. Yong, D., K. Lee, J. H. Yum, H. B. Shin, G. M. Rossolini, and Y. Chong. 2002. Imipenem-EDTA disk method for differentiation of metallo-β-lactamase- producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 40:3798-3801.
29. Zavascki, A. P., A. L. Barth, P. B. Gaspareto, A. L. Gonçalves, A. L. Moro, J. F. Fernandes, and L. Z. Goldani. 2006. Risk factors for nosocomial infections due to Pseudomonas aeruginosa producing metallo-β-lactamase in two tertiary-care teaching hospitals. J. Antimicrob. Chemother. 58:882-885.